Approach to Acute Cardiovascular Complications in COVID-19 Infection

Cardiovascular Risk and Diseases

Multimodality Imaging in Evaluation of Cardiovascular complications in Patients with COVID-19

J Am Coll Cardiol.

Rudski L, Januzzi JL, Rigolin VH, Bohula EA, Blankstein R, Patel AR, Bucciarelli-Ducci C, Vorovich E, Mukherjee M, Rao SV, Beanlands R, Villines TC, Di Carli MF

doi: 10.1016/j.jacc.2020.06.080.

Further Publications

Declines in Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic: A Multicenter Tertiary Care Experience

J Am Coll Cardiol.

Bhatt AS, Moscone A, McElrath EE, Varshney AS, Claggett BL, Bhatt DL, Januzzi JL, Butler J, Adler DS, Solomon SD, Vaduganathan M

doi: 10.1016/j.jacc.2020.05.038.

Further Publications

The Science Underlying COVID-19: Implications for the Cardiovascular System

Circulation.

Liu PP, Blet A, Smyth D, Li H

doi: 10.1161/CIRCULATIONAHA.

Cardiovascular Risk and Diseases

Cardiac complications in patients hospitalised with COVID-19

Eur Heart J Acute Cardiovasc Care

Linschoten M, Peters S, van Smeden M, Jewbali LS, Schaap J, Siebelink HM, Smits PC, Tieleman RG, van der Harst P, van Gilst WH, Asselbergs FW, CAPACITY-COVID collaborative consortium.

doi: 10.1177/2048872620974605

Myocardial Infarction

Management of Acute Myocardial Infarction During the COVID-19 Pandemic

J Am Coll Cardiol.

Mahmud E, Dauerman HL, Welt FG, Messenger JC, Rao SV, Grines C, Mattu A, Kirtane AJ, Jauhar R, Meraj P, Rokos IC, Rumsfeld JS, Henry TD

doi: 10.1016/j.jacc.2020.04.039.

Cardiovascular Risk and Diseases

Cardiovascular biomarkers in patients with COVID-19

Eur Heart J Acute Cardiovasc Care

Mueller C, Giannitsis E, Jaffe AS, Huber K, Mair J, Cullen L, Hammarsten O, Mills NL, Möckel M, Krychtiuk K, Thygesen K, Lindahl B, ESC Study Group on Biomarkers in Cardiology of the Acute Cardiovascular Care Association.

doi: 10.1093/ehjacc/zuab009

Cardiovascular Risk and Diseases

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Clin Res Cardiol.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, Bi Z, Zhao Y

doi: 10.1007/s00392-020-01626-9.

Cardiovascular Risk and Diseases

Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors

J Am Heart Assoc.

Gupta AK, Jneid H, Addison D, Ardehali H, Boehme AK, Borgaonkar S, Boulestreau R, Clerkin K, Delarche N, DeVon HA, Grumbach IM, Gutierrez J, Jones DA, Kapil V, Maniero C, Mentias A, Miller PS, May Ng S, Parekh JD, Sanchez RH, Teodor Sawicki K, S J M Te Riele A, Ann Remme C, London B

doi: 10.1161/JAHA.120.017013.

Further Publications

COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?

J Am Heart Assoc.

Larson AS, Savastano L, Kadirvel R, Kallmes DF, Hassan AE, Brinjikji W

doi: 10.1161/JAHA.120.016793.

Related content

Multimodality Imaging in Evaluation of Cardiovascular complications in Patients with COVID-19

Declines in Hospitalizations for Acute Cardiovascular Conditions During the COVID-19 Pandemic: A Multicenter Tertiary Care Experience

The Science Underlying COVID-19: Implications for the Cardiovascular System

Cardiac complications in patients hospitalised with COVID-19

Management of Acute Myocardial Infarction During the COVID-19 Pandemic

Cardiovascular biomarkers in patients with COVID-19

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors

COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?